Infrastructure from old coal power plants is being re-purposed to support clean energy projects.
Articles
Elon Musk: Tesla may cut prices again in 'turbulent times'
Elon Musk is mulling price-cuts for Tesla vehicles, even as profit margins slide.
Fifa esports World Cup finalists respond to penalty row
Controversy among competitors in a major esports tournament that was decided on the basis of penalties awarded.
Amazon Is Rolling Out Palm Payments to All 500+ Whole Foods Stores
Amazon seeks to increase penetration of its palm payments terminal via this latest deal with Whole Foods.
Tech industry, university leaders discuss workforce challenges with Sen. Kyrsten Sinema
Arizona looks to increase its tech footprint by building a skilled workforce.
Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need
Damage to Pfizer's North Carolina factory could impact the supply of several pharmaceuticals.
atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update
Atai reports its Q2 2022 results, announces a new $175 million loan facility and streamlines its operations.
MindMed Board of Directors Approves Reverse Share Split
Mind Medicine announces a reverse share split of its common shares at a 1-15 ratio. Exchange symbols will remain the same but new CUSIP numbers will be assigned by the appropriate regulators.
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights
Compass Pathways reports its Q2 2022 results. Preparing for its Phase 3 clinical trial for TRD. Net loss of $21.0 million. Cash (and equivalents) of $207.2 million.
COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa
Compass Pathways announces the launch of a Phase II clinical trial using psilocybin-based COMP360 as a treatment for anorexia nervosa.
Red Light Holland to Acquire Two Wellness Shops in the Netherlands: SmartShop Utrecht and SmartShop OSS
Red Light Holland acquires two of the Netherlands premier shops for psychedelic truffles and wellness products.
Pasithea Therapeutics Awarded a Drug Development Research Grant
Pasithea Therapeutics announces being awarded a research grant of AUD $1 million (US$694,000) for its psychedelics-based research for ALS disease.
Awakn Life Sciences' Phase III Trial Approved for Approximately CA$2.5 Million Funding from UK State Covering 66% of Costs
Awakn Life Sciences announces UK government grant funding to cover 2/3rds of the costs of its Phase III clinical trial for alcohol use disorder (AUD).
COMPASS Pathways appoints Kabir Nath as Chief Executive Officer
Compass Pathways announces that Kabir Nath will replace George Goldsmith as CEO effective August 1, 2022.
BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies
Better Life Pharma announces additional funding to study BETR-001 as a treatment for depression, via the Mitacs Accelerate program.